FORWARD FEATURES CALENDAR

Funds

Tikehau IM supports Abénex for the acquisition of Cisbio Bioassays

Tikehau IM has acted as sole lead arranger of a EUR35 million unitranche denominated in USD for the acquisition of Cisbio Bioassays by Abénex.  Abénex acquires Cisbio Bioassays in a secondary LBO from Argos Soditic. Flexible unitranche financing denominated in US$ has been arranged by Tikehau IM.  Cisbio Bioassays is

Once secures further EUR5m in investment

Dating app Once has secured a second wave of investment from Partech, the French venture capital firm, that supports global companies that they believe possess revolutionary concepts.  For this reason, Partech Ventures has just signed a second partnership deal with Once to invest a further one million euros in the

Allecra Therapeutics secures EUR22m Series B financing

Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics to combat drug-resistant bacterial infections, has closed a EUR22 million Series B investment round.  The round was led by new investor, Delos Capital.  Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures and Allecra's co-Founder

OPIC makes USD250m investment in telecom tower infrastructure project

The Overseas Private Investment Corporation (OPIC), the US government’s development finance institution, has commenced the initial disbursement of a USD250 million loan to Apollo Towers Myanmar Limited, based in Yangon.  The disbursement marks OPIC’s first financing in the country as well as a historic milestone in public-private cooperation. Investors TPG

OMAM to acquire majority interest in Landmark Partners

OM Asset Management (OMAM) is to acquire a 60 per cent equity interest in Landmark Partners, a secondary private equity, real estate and real asset investment firm.  Under the terms of the purchase agreement, OMAM will pay approximately USD240 million in cash at closing with the potential for an additional

Hamilton Lane holds final close on Strategic Opportunities Fund 2016

Hamilton Lane has held the final closing of Hamilton Lane Strategic Opportunities Fund 2016 with more than USD210 million in limited partner commitments, exceeding its initial target of USD150 million. The Fund was created as a unique solution for LPs seeking short duration, risk-adjusted returns.  Structured as an annual series

Ai Squared joins VFO

VFO, the company behind the Freedom Scientific and Optelec brands, has acquired Ai Squared, a developer of screen magnification and screen reading software.  Together, the companies offer the world’s broadest suite of assistive technology products for the visually-impaired. Each of the companies has a long history of providing innovative technology

IK to partner with OpenSolution founder

IK Investment Partners’ (IK) IK Small Cap I Fund is to acquire a majority stake in OS Group AB (OpenSolution), a Nordic payment solution provider, from the company’s founder. Financial terms of the transaction have not been disclosed. Headquartered in Gothenburg, Sweden, OpenSolution offers a full service product and software

Armeron raises USD2m from Glilot Capital Partners

Armeron recently secured funding of USD2 million from Glilot Capital Partners, a venture capital fund specialising in Enterprise Software. Armeron's isolation platform is a drastic departure from today's filtering-based approach to web application protection such as Web Application Firewalls. These first generation approaches rely on a mix of signatures and

Events

12 November, 2026 – 5:00 pm

Directory Listings